Q3 2016 Holdings
Filed 2016-11-14 | 196 holdings | $75.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | Common Stock | 01438T106 | $15.2M | 1,940,458 | 20.1% |
| Ardelyx Inc(ARDX) | Common Stock | 039697107 | $13.7M | 1,057,257 | 18.1% |
| Aclaris Therapeutics Inc(ACRS) | Common Stock | 00461U105 | $11.0M | 430,000 | 14.6% |
| Akebia Therapeutics Inc(AKBA) | Common Stock | 00972D105 | $7.3M | 809,096 | 9.7% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common Stock | 04280A100 | $6.2M | 847,458 | 8.2% |
| Adma Biologics Inc(ADMA) | Common Stock | 000899104 | $5.3M | 734,793 | 7.1% |
| Cellectis ADR(CLLS) | Depository Receipt | 15117K103 | $4.3M | 179,506 | 5.7% |
| Beigene LTD(ONC) | Depository Receipt | 07725L102 | $4.1M | 132,057 | 5.4% |
| Acadia Pharmaceuticals Inc(ACAD) | Common Stock | 004225108 | $2.1M | 65,240 | 2.7% |
| BIO RAD Laboratories Class A(BIO) | Common Stock | 090572207 | $1.6M | 10,000 | 2.2% |
| ANI Pharmaceuticals Inc(ANIP) | Common Stock | 00182C103 | $767.0K | 11,561 | 1.0% |
| Champions Oncology Inc(CSBR) | Common Stock | 15870P307 | $625.0K | 372,597 | 0.8% |
| Biogen Inc(BIIB) | Common Stock | 09062X103 | $601.0K | 1,921 | 0.8% |
| Charles River Laboratories(CRL) | Common Stock | 159864107 | $457.0K | 5,482 | 0.6% |
| AMN Healthcare Inc(AMN) | Common Stock | 001744101 | $428.0K | 13,445 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | Common Stock | 803607100 | $208.5K | 3,395,236 | 0.3% |
| Accuray Inc(ARAY) | Common Stock | 004397105 | $174.0K | 27,300 | 0.2% |
| Atricure Inc(ATRC) | Common Stock | 04963C209 | $126.0K | 7,949 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | Common Stock | 64125C109 | $125.4K | 2,476,272 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | Common Stock | 03152W109 | $104.5K | 14,116,644 | 0.1% |
| Tesaro Inc | Common Stock | 881569107 | $68.4K | 682,415 | 0.1% |
| Retrophin Inc | Common Stock | 761299106 | $54.8K | 2,446,482 | 0.1% |
| Global Blood Therapeutics Inc | Common Stock | 37890U108 | $53.8K | 2,334,168 | 0.1% |
| Versartis Inc | Common Stock | 92529L102 | $49.4K | 4,028,685 | 0.1% |
| Nxstage Medical Inc | Common Stock | 67072V103 | $41.7K | 1,669,703 | 0.1% |
| Xencor Inc(XNCR) | Common Stock | 98401F105 | $36.6K | 1,496,229 | 0.0% |
| LA Jolla Pharmaceutical Company(LJPC) | Common Stock | 503459604 | $31.5K | 1,323,324 | 0.0% |
| Lion Biotechnologies Inc | Common Stock | 53619R102 | $29.4K | 3,567,553 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN) | Common Stock | 09061G101 | $23.0K | 250 | 0.0% |
| Wave Life Sciences LTD(WVE) | Common Stock | Y95308105 | $22.2K | 683,448 | 0.0% |
| Acceleron Pharma Inc(XLRN) | Common Stock | 00434H108 | $21.3K | 589,890 | 0.0% |
| Colucid Pharmaceuticals Inc | Common Stock | 19716T101 | $21.1K | 552,030 | 0.0% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | Common Stock | 00444T100 | $21.0K | 5,408,728 | 0.0% |
| Quotient LTD | Common Stock | G73268107 | $20.9K | 2,671,794 | 0.0% |
| DBV Technologies SA | Depository Receipt | 23306J101 | $20.5K | 563,268 | 0.0% |
| Corbus Pharmaceuticals Holdings(CRBPEUR) | Common Stock | 21833P103 | $18.3K | 2,701,023 | 0.0% |
| Regenxbio Inc(RGNX) | Common Stock | 75901B107 | $18.0K | 1,282,286 | 0.0% |
| Radius Health Inc | Common Stock | 750469207 | $17.0K | 313,502 | 0.0% |
| Flamel Technologies | Depository Receipt | 338488109 | $16.9K | 1,363,711 | 0.0% |
| Kadmon Inc(KDMN) | Common Stock | 48283N106 | $16.2K | 2,209,657 | 0.0% |
| Dexcom Inc(DXCM) | Common Stock | 252131107 | $15.7K | 178,849 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | Common Stock | 00771V108 | $15.4K | 406,771 | 0.0% |
| Blueprint Medicines Corp(2L9) | Common Stock | 09627Y109 | $13.7K | 460,024 | 0.0% |
| Depomed Inc | Common Stock | 249908104 | $13.4K | 535,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | Common Stock | 014339105 | $12.8K | 391,280 | 0.0% |
| Foamix Pharmaceuticals LTD | Common Stock | M46135105 | $12.7K | 1,373,284 | 0.0% |
| Cytomx Therapeutics, Inc | Preferred Stock | 232996751 | $11.6K | 742,021 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | Common Stock | 603380106 | $11.4K | 810,537 | 0.0% |
| Zynerba Pharmaceuticals Inc | Common Stock | 98986X109 | $11.3K | 868,897 | 0.0% |
| Dermira Inc(DERMEUR) | Common Stock | 24983L104 | $11.2K | 331,610 | 0.0% |